Lou Gehrig's Disease
Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig's disease, is a progressive neurodegenerative condition affecting motor neurons. Full Extract Cannabis Oil (FECO) is increasingly utilized as a powerful palliative tool to manage symptoms and potentially slow certain aspects of disease progression.
Therapeutic Benefits for ALS
Research suggests that cannabis has several properties—antioxidant, anti-inflammatory, and neuroprotective—that are directly relevant to the pathology of ALS.
Reduction of Spasticity and Cramping: One of the most distressing symptoms of ALS is muscle stiffness and painful spasms. The combination of THC and CBD in FECO acts as a muscle relaxant, helping to ease the physical tension and discomfort in the limbs.
Saliva Management (Sialorrhea): Many ALS patients struggle with excess saliva, which can lead to choking or drooling. THC is known to cause dry mouth (xerostomia), which in this specific context serves as a therapeutic benefit by drying up excess secretions.
Appetite Stimulation and Weight Maintenance: Maintaining weight is crucial for ALS patients to preserve muscle mass. FECO can stimulate appetite and help manage the nausea or depression that often leads to caloric deficits.
Pain Management: ALS causes pain through several channels: immobility, pressure sores, and neuropathy. FECO provides systemic analgesia that is often more tolerable than high-dose opioids, which can further suppress respiratory function.
Neuroprotection and Glutamate Regulation: One theory behind ALS progression is "glutamate excitotoxicity" (where too much glutamate kills nerve cells). Studies have shown that certain cannabinoids can help regulate glutamate levels and provide antioxidant support to stressed motor neurons.
Sleep and Psychological Support: The profound anxiety and insomnia associated with a progressive diagnosis can be mitigated by the sedating, "full-spectrum" effect of FECO, particularly those high in the terpene Myrcene.
Symptom Management Comparison
| ALS Symptom | Traditional Approach | FECO Potential Role |
|---|---|---|
| Spasticity | Baclofen / Tizanidine | Natural muscle relaxant with fewer "rebound" effects. |
| Excess Saliva | Glycopyrrolate / Botox | Systemic drying effect through cannabinoid receptors. |
| Pain | NSAIDs / Opioids | Multi-pathway pain relief; helps with nerve and muscle pain. |
| Mood/Sleep | SSRIs / Hypnotics | Improves sleep latency and reduces disease-related anxiety. |
Administration for ALS Patients
As ALS progresses, the method of delivery becomes very important due to potential swallowing difficulties (dysphagia).
Sublingual Absorption: Placing FECO under the tongue allows it to enter the bloodstream directly, bypassing the need to swallow a large pill or capsule.
Feeding Tubes (G-Tube): For patients with advanced ALS, FECO can be easily thinned with a carrier oil (like coconut or MCT oil) and administered directly through a feeding tube.
Dosing: Patients typically start with a tiny amount (the size of a pinhead) and titrate up slowly to find a balance between symptom relief and motor function.
[!CAUTION]
Respiratory Health: Because ALS affects the muscles used for breathing, FECO should generally be ingested or used sublingually. Smoking or vaping is highly discouraged for ALS patients as it can further irritate the lungs and compromise oxygen intake.
